U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H11NO4S
Molecular Weight 253.274
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ACTINOQUINOL

SMILES

CCOC1=CC=C(C2=CC=CN=C12)S(O)(=O)=O

InChI

InChIKey=YAMVZYRZAMBCED-UHFFFAOYSA-N
InChI=1S/C11H11NO4S/c1-2-16-9-5-6-10(17(13,14)15)8-4-3-7-12-11(8)9/h3-7H,2H2,1H3,(H,13,14,15)

HIDE SMILES / InChI

Molecular Formula C11H11NO4S
Molecular Weight 253.274
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22480421 | https://www.ncbi.nlm.nih.gov/pubmed/23075132

Actinoquinol is sunscreen agent that absorbs Ultraviolet B light. Actinoquinol in combination with hyaluronic acid drops might be helpful for the human eye in the defense against photooxidative and other oxidative processes.

Originator

Sources: Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation) (1932), 5, 803-8.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
The effect of actinoquinol with hyaluronic acid in eye drops on the optical properties and oxidative damage of the rabbit cornea irradiated with UVB rays.
2010 Nov-Dec
Patents

Patents

Sample Use Guides

The sterile buffered solution of 0.2 % actinoquinol with 0.15 % hyaluronic acid, pH 7.2 was dropped on the right eye (one drop every 30 s, five drops in total)
Route of Administration: Topical
The inhibition of EBV-EA activation was assayed using the EBV genome carrying lymphoblastoid Raji cells of human origin, which were cultivated in RPMI 1640 medium. The cells were incubated at 370 C for 48 h in 1 mL of the medium containing butyric acid (4 mM, as co-inducer), TPA (20 ng/mL, 32 pM) and a known amount of Actinoquinol in DMSO. Smears were made from cell suspension. The EBV-EA-expressing cells were stained with high titre EBV-EA-positive serum from nasopharyngeal carcinoma patients and detected by an indirect immunofluorescence technique. In each assay, 500 cells were counted, and the experiments were carried out in triplicate. The average EA induction was compared to that of a positive control experiment with butyric acid (4 mM) and TPA (32 pM).
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:17:22 GMT 2023
Edited
by admin
on Fri Dec 15 17:17:22 GMT 2023
Record UNII
470VQE23O3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ACTINOQUINOL
INN   MI   WHO-DD  
INN  
Official Name English
ACTINOQUINOL [MI]
Common Name English
8-ETHOXY-5-QUINOLINESULFONIC ACID
Systematic Name English
NSC-165584
Code English
Actinoquinol [WHO-DD]
Common Name English
actinoquinol [INN]
Common Name English
5-QUINOLINESULFONIC ACID, 8-ETHOXY-
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28394
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
Code System Code Type Description
WIKIPEDIA
Actinoquinol
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
MERCK INDEX
m5
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY Merck Index
DRUG CENTRAL
3664
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
CAS
15301-40-3
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
NSC
165584
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
NCI_THESAURUS
C76254
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
EVMPD
SUB05256MIG
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
ChEMBL
CHEMBL1356732
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
SMS_ID
100000087695
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
PUBCHEM
23674
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
EPA CompTox
DTXSID4046521
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
FDA UNII
470VQE23O3
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
ECHA (EC/EINECS)
239-334-9
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
MESH
C556636
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
INN
1626
Created by admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY